High efficiency transfection of porcine vascular cells in vitro with a synthetic vector system

Journal of Gene Medicine

Volumn 4, Issue 3, 2002, Pages 292-299

  Parkes, Richard ^a   Meng, Qing Hai ^a   Siapati, K Elena ^a   McEwan, Jean R ^b   Hart, Stephen L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cardiovascular disease; Endothelial cells; Gene therapy; Non viral; Smooth muscle cells

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTEGRIN; LIPOSOME; LUCIFERASE; PLASMID DNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; DNA;

ANIMAL CELL; ANIMAL CELL CULTURE; AORTA; ARTICLE; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DNA DETERMINATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPORTER GENE; SMOOTH MUSCLE FIBER; SWINE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; STANDARD;

SUIDAE;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; DNA; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; SWINE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION;

EID: 0036581643     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.265     Document Type: Article

References (20)

1. Baek S, March KL. Gene therapy for restenosis: getting nearer the heart of the matter. Circ Res 1998; 82: 295-305.
2. Pickering JG, Jekanowski J, Weir L, et al. Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation 1994; 89: 13-21.
3. Lawrie A, Brisken AF, Francis SE, et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 1999; 99: 2617-2620.
4. Laitinen M, Pakkanen T, Donetti E, et al. Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum Gene Ther 1997; 8: 1645-1650.
5. Hart SL, Arancibia-Carcamo CV, Wolfert MA, et al. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther 1998; 9: 575-585.
6. Hart SL, Collins L, Gustafsson K, Fabre JW. Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains. Gene Ther 1997; 4: 1225-1230.
7. Hart SL, Harbottle RP, Cooper R, et al. Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther 1995; 2: 552-554.
8. Hart SL, Knight AM, Harbottle RP, et al. Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 1994; 269: 12468-12474.
9. Itoh H, Nelson PR, Mureebe L, et al. The role of integrins in saphenous vein vascular smooth muscle cell migration. J Vasc Surg 1997; 25: 1061-1069.
10. George SJ, Johnson JL, Angelini GD, et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther 1998; 9: 867-877.
11. Dollery CM, Humphries SE, McClelland A, et al. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 1999; 99: 3199-3205.
12. Pearson JD, Carleton JS, Hutchings A. Prostacyclin release stimulated by thrombin or bradykinin in porcine endothelial cells cultured from aorta and umbilical vein. Thromb Res 1983; 29: 115-124.
13. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastin fibres. J Cell Biol 1971; 50 172-186.
14. Tanaka K, Iwamoto Y, Ito Y, et al. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res 1995; 55: 2927-2935.
15. Webb KE, Henney AM, Anglin S, et al. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 1997; 17: 1837-1844.
16. Koivunen E, Wang B, Ruoslahti E. Isolation of a highly specific ligand for the α5β1 integrin from a phage display library. J Cell Biol 1994; 124: 373-380.
17. O'Sullivan M, Bennett MR. Gene therapy for coronary restenosis: is the enthusiasm justified? Heart 2001; 86: 491-493.
18. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998; 101: 1478-1487.
19. Forough R, Koyama N, Hasenstab D, et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 1996; 79: 812-820.
20. Baker AH, Wilkinson GW, Hembry RM, et al. Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells. Matrix Biol 1996; 15 383-395.